Page last updated: 2024-10-24

cgs 15943 and Diathesis

cgs 15943 has been researched along with Diathesis in 1 studies

9-chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine: non-xanthine triazoloquinazoline adenosine antagonist
CGS 15943 : A member of the class of triazoloquinazolines that is [1,2,4]triazolo[1,5-c]quinazoline substited at positions 2, 5 and 9 by furan-2-yl, amino and chloro groups respectively. A potent antagonist at adenosine A1 and adenosine A2A receptors.

Research Excerpts

ExcerptRelevanceReference
"CGS 15943 A (1 mg/kg) was given 15 min before both tests and all the drugs were administered i."1.28Influence of CGS 15943 A (a nonxanthine adenosine antagonist) on the protection offered by a variety of antiepileptic drugs against maximal electroshock-induced seizures in mice. ( Czuczwar, SJ; Janusz, W; Kleinrok, Z; Szczepanik, B, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Czuczwar, SJ1
Janusz, W1
Szczepanik, B1
Kleinrok, Z1

Other Studies

1 other study available for cgs 15943 and Diathesis

ArticleYear
Influence of CGS 15943 A (a nonxanthine adenosine antagonist) on the protection offered by a variety of antiepileptic drugs against maximal electroshock-induced seizures in mice.
    Journal of neural transmission. General section, 1991, Volume: 86, Issue:2

    Topics: Adenosine; Animals; Anticonvulsants; Disease Susceptibility; Drug Interactions; Electroshock; Epilep

1991